OraSure Technologies, Inc. - Common Stock (OSUR)
Frequently Asked Questions About OraSure Technologies, Inc. - Common Stock (OSUR)
How does OraSure contribute to public health?
OraSure contributes to public health by developing innovative diagnostic solutions that facilitate the detection and monitoring of infectious diseases. Their products help individuals receive timely medical care and support public health initiatives aimed at controlling disease outbreaks and improving overall health outcomes.
How does OraSure ensure the quality of its products?
OraSure ensures the quality of its products through rigorous quality control measures and compliance with regulatory standards set by institutions like the FDA and CLIA. The company implements systematic testing and operational protocols throughout the production and testing process.
Is OraSure Technologies publicly traded?
Yes, OraSure Technologies is publicly traded on the NASDAQ stock exchange under the ticker symbol OSUR. The company’s stock is available for investment, and it is monitored by investors and analysts in the biotechnology sector.
What are analysts saying about OraSure Technologies?
Analysts generally have a mixed outlook on OraSure Technologies, with assessments based on the company's financial performance, product pipeline, and market position. Investor sentiment can vary based on market conditions and competitive developments within the biotechnology sector.
What are some challenges faced by OraSure Technologies?
OraSure Technologies faces challenges such as competition in the rapidly evolving biotech market, regulatory hurdles in obtaining and maintaining compliance for its products, and the need to continually innovate to meet changing healthcare demands and consumer expectations.
What are some recent developments from OraSure Technologies?
Recent developments from OraSure Technologies include advancements in their COVID-19 testing solutions and ongoing innovations in oral fluid testing technologies. The company has actively participated in addressing public health emergencies, showcasing its commitment to adaptive and responsive healthcare solutions.
What does OraSure Technologies, Inc. do?
OraSure Technologies, Inc. is a biotechnology company that specializes in developing, manufacturing, and distributing oral fluid and blood-based diagnostic tests as well as specimen collection devices. Their products are used primarily for infectious disease testing, including HIV, HCV, and COVID-19, as well as for providing solutions in drug testing and other medical diagnostics.
What is OraSure's corporate culture like?
OraSure's corporate culture emphasizes innovation, collaboration, and a commitment to public health. The company fosters an environment of teamwork and encourages its employees to contribute to its mission of developing effective healthcare solutions.
What is OraSure's mission?
OraSure's mission is to provide innovative, accurate, and accessible diagnostic solutions that enhance patient care and improve public health. The company is dedicated to advancing technologies that promote health awareness, early disease detection, and effective monitoring.
What is the company's approach to research and development?
OraSure places a strong emphasis on research and development (R&D) to drive innovation in the diagnostic field. The company invests significantly in R&D to improve existing products and develop new testing technologies to meet evolving healthcare needs.
What is the impact of COVID-19 on OraSure's business?
The COVID-19 pandemic had a significant impact on OraSure's business, leading to an increased demand for testing solutions. The company adapted its product offerings to include COVID-19 testing kits, which helped it to contribute to public health efforts while also bolstering its revenue during the pandemic.
What is the significance of OraSure's oral fluid testing products?
OraSure's oral fluid testing products are significant because they provide a non-invasive method for collecting samples, which can increase accessibility and comfort for patients. These tests are particularly important for sensitive applications such as HIV testing, allowing for more widespread screening and reducing barriers to testing.
What markets does OraSure operate in?
OraSure operates primarily in the healthcare and biotechnology markets, focusing on diagnostics for infectious diseases, drug testing, and sample collection. Additionally, it serves researchers and public health organizations globally, addressing critical health issues through its products.
What types of products does OraSure offer?
OraSure offers a range of products that include diagnostic tests for infectious diseases (such as oral fluid tests for HIV and HCV), specimen collection devices, and drug screening tests. Their offerings also extend to laboratory services and solutions that aid in medical diagnostics.
When was OraSure Technologies founded?
OraSure Technologies was founded in 1987. Over the years, it has established itself as a leader in the field of oral fluid diagnostics, making significant contributions to the public health and medical fields through its innovative products.
Where is OraSure Technologies headquartered?
OraSure Technologies is headquartered in Bethlehem, Pennsylvania, USA. The company operates out of state-of-the-art facilities that include research, development, and manufacturing operations.
Who are OraSure's competitors?
OraSure's competitors include other biotechnology and diagnostic firms that develop similar testing and specimen collection products, such as Abbott Laboratories, Roche Diagnostics, and OraSure’s smaller rivals in the sectors of oral fluid testing and drug screening.
Who are the key executives at OraSure Technologies?
Key executives at OraSure Technologies include the Chief Executive Officer, the Chief Financial Officer, and heads of various divisions such as research and development, sales, and marketing. These leaders guide the company's strategic direction and operational execution.
What is the current price of OraSure Technologies, Inc. - Common Stock?
The current price of OraSure Technologies, Inc. - Common Stock is 2.790
When was OraSure Technologies, Inc. - Common Stock last traded?
The last trade of OraSure Technologies, Inc. - Common Stock was at 4:00 pm EDT on October 29th, 2025
What is the market capitalization of OraSure Technologies, Inc. - Common Stock?
The market capitalization of OraSure Technologies, Inc. - Common Stock is 204.40M
How many shares of OraSure Technologies, Inc. - Common Stock are outstanding?
OraSure Technologies, Inc. - Common Stock has 73.26M shares outstanding.